NasdaqGS - Nasdaq Real Time Price USD

Pacira BioSciences, Inc. (PCRX)

26.33
+0.18
+(0.71%)
As of 11:55:06 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
702,772
700,966
674,978
666,823
541,533
Cost of Revenue
157,318
170,428
184,669
199,295
140,255
Gross Profit
545,454
530,538
490,309
467,528
401,278
Operating Expense
454,818
432,964
402,986
396,601
268,443
Operating Income
90,636
97,574
87,323
70,927
132,835
Net Non Operating Interest Income Expense
4,848
3,120
-8,862
-35,434
-30,854
Other Income Expense
-163,524
-163,800
-16,760
-22,191
-45,577
Pretax Income
-68,040
-63,106
61,701
13,302
56,404
Tax Provision
35,687
36,454
19,746
-2,607
14,424
Net Income Common Stockholders
-103,727
-99,560
41,955
15,909
41,980
Average Dilution Earnings
-1,029
0
4,114
0
--
Diluted NI Available to Com Stockholders
-104,756
-99,560
46,069
15,909
41,980
Basic EPS
-2.24
-2.15
0.91
0.35
0.95
Diluted EPS
-2.24
-2.15
0.89
0.34
0.92
Basic Average Shares
46,189
46,245
46,222
45,521
44,262
Diluted Average Shares
46,189
46,245
51,979
46,538
45,630
Total Operating Income as Reported
-84,593
-73,371
87,675
60,024
89,924
Total Expenses
612,136
603,392
587,655
595,896
408,698
Net Income from Continuing & Discontinued Operation
-103,727
-99,560
41,955
15,909
41,980
Normalized Income
28,764.69
29,547.33
53,225.32
24,522.37
73,918.66
Interest Income
22,681
19,689
11,444
4,542
896
Interest Expense
14,539
13,439
17,310
35,576
28,996
Net Interest Income
4,848
3,120
-8,862
-35,434
-30,854
EBIT
-53,501
-49,667
79,011
48,878
85,400
EBITDA
28,026
29,118
154,585
140,379
113,948
Reconciled Cost of Revenue
133,079
148,931
166,383
165,082
125,260
Reconciled Depreciation
81,527
78,785
75,574
91,501
28,548
Net Income from Continuing Operation Net Minority Interest
-103,727
-99,560
41,955
15,909
41,980
Total Unusual Items Excluding Goodwill
-167,711
-163,427
-16,574
-10,903
-42,911
Total Unusual Items
-167,711
-163,427
-16,574
-10,903
-42,911
Normalized EBITDA
195,737
192,545
171,159
151,282
156,859
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-35,219.31
-34,319.67
-5,303.68
-2,289.63
-10,972.34
12/31/2021 - 2/3/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COLL Collegium Pharmaceutical, Inc.
29.92
+0.28%
 
CPIX Cumberland Pharmaceuticals Inc.
5.38
-1.28%
 
ELAN Elanco Animal Health Incorporated
13.19
-0.23%
 
SCYX SCYNEXIS, Inc.
0.8299
-0.25%
 
SUPN Supernus Pharmaceuticals, Inc.
32.98
-0.21%
 
ETON Eton Pharmaceuticals, Inc.
19.56
-0.08%
 
IRWD Ironwood Pharmaceuticals, Inc.
0.6193
+1.21%
 
4506.T Sumitomo Pharma Co., Ltd.
833.00
-0.72%
 
ORGO Organogenesis Holdings Inc.
3.2100
-0.62%
 
RDY Dr. Reddy's Laboratories Limited
14.47
+0.07%